Showing results (581-590 of 843) with videos related to

Sort By:
Pageof 85
Journal of Virology|February 4, 2012
Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine designMattia Bonsignori, David C Montefiori, Xueling Wu, et al.
Plos One|October 8, 2011
Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sortingLynn Morris, Xi Chen, Munir Alam, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 27, 2022
Humanized V(D)J-rearranging and TdT-expressing mouse vaccine models with physiological HIV-1 broadly neutralizing antibody precursorsSai Luo, Changbin Jing, Adam Yongxin Ye, et al.
The Journal of Clinical Investigation|October 2, 2014
HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trialPierre-Alexandre Bart, Yunda Huang, Shelly T Karuna, et al.
Viruses|October 28, 2015
Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV VariantsPeter Hraber, Bette Korber, Kshitij Wagh, et al.
Ebiomedicine|August 20, 2015
Structural analysis of the unmutated ancestor of the HIV-1 envelope V2 region antibody CH58 isolated from an RV144 vaccine efficacy trial vaccineeNathan I Nicely, Kevin Wiehe, Thomas B Kepler, et al.
Nature Medicine|February 23, 2010
Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeysSampa Santra, Hua-Xin Liao, Ruijin Zhang, et al.
Plos Pathogens|April 22, 2009
A critical role for CD8 T cells in a nonhuman primate model of tuberculosisCrystal Y Chen, Dan Huang, Richard C Wang, et al.
The Journal of Experimental Medicine|May 6, 2009
Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1Brandon F Keele, Hui Li, Gerald H Learn, et al.
Plos Pathogens|March 27, 2019
Correction: HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodiesCelia C LaBranche, Andrew T McGuire, Matthew D Gray, et al.
Pageof 85